// App-Quantinova.ai

B147 : Comparative effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty

Researchers

Presenter

  • JF Reichel

Principal Investigators

  • CJ DeFrancesco

  • M Popovic

  • E Gbaje

  • J Liu

  • SC Haskins

  • DH Kim

  • DB Maalouf

  • MA Kirksey

  • KM Jules-Elysee

  • EM Soffin

  • K Kumar

  • JC Beathe

  • S Garvin

  • K DelPizzo

  • J Saleh

  • H Zhong

  • SG Memtsoudis

Medical Centers

  • Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery, New York, USA

  • Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, USA

  • Department of Anesthesiology, Weill Cornell Medical College, New York, USA

  • Pharmacy Department, Hospital for Special Surgery, New York, USA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • E3 ubiquitin-protein ligase CBL

Drug/Treatment

  • Tranexamic acid

  • Caprilon

Outcome

  • N/A

Study Design

  • Randomized

  • Non Inferiority

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved